Replies to post #4551986 on BB's Stock Haven

[puffadder]

ASKH Crazy Low Price and Float SEC Filer is Icing

[Sean Portman]

$IRNC approved for a blockchain patent. Blowing the top off of this before PR comes out. Awaiting 6 more patents. When 8K comes out it will be too late to buy cheap. Ironclad owns 7 patents already

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=%22Lerner+Daniel+Maurice%22&OS=%22Lerner+Daniel+Maurice%22&RS=%22Lerner+Daniel+Maurice%22

[Magnum7419]

Great spec stock........but it is sad that no body seems interested in NLOK . Where can one finally buy a Nasdaq investment stock and immediately receive a cash dividend of 40% .......?

"NortonLifeLock (NASDAQ: NLOK) (the “Company”) today announced that its Board of Directors has declared a special, one-time cash dividend of $12 per share of NortonLifeLock Inc. common stock, returning over $8 billion of capital to shareholders. The dividend is payable on January 31, 2020 to all shareholders of record as of the close of business on January 23, 2020. Shareholders of record on January 23, 2020 must hold their shares through the close of January 31 payment date to receive the special dividend. The ex-dividend date will be February 3, 2020, the first business day after such payment date"

[swanlinbar]

"ASKH 10Q out late Friday with hints of a merger. IMO everyone should have a piece of this.

SEC Filer DD Summary:

- OS 29,890,066 unchanged since 12/17
- Float 21,730,066 unchanged since 12/17
- SEC filer
- CEO owns 8,160,000 shares (IQ Acquisition NY Ltd.)
- ZERO TOXIC DEBT
- 10Q for 9/30/19 includes Subsequent Event - Merger raise $20 mil
- State of Florida reinstatement 10/31/19
- Merger partner expected to include significant revenue producing assets
- CEO has extensive Southeast Asian background
- Market cap at time of posting $762k for an SEC filer?
- https://www.otcmarkets.com/stock/ASKH/overview"; Could be anytime now!

[winnotlose]

Clwd my friend

[Jack_of_All_Trades]

ASKH heading north again -- on watch for 8K!

[stock1ace1]

Bimi $4.27 **** monday gap watch

[stock1ace1]

LKCO @$1.23 News Out w/ Ford !!

[stock1ace1]

XALL @.0025 *** broke 50 Huge accumulation 211 mill float

[stock1ace1]

XALL @.0027 Up !! Broke 50MA bitcoin 211 Mill Float

Updates coming

https://www.barchart.com/stocks/quotes/XALL/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(200);SMA(50);SMACD(12,26,9)&sym=XALL&grid=1&height=210&studyheight=100

[NorthShoreTrading]

VTNL huge PR just now, $7 mill revs this year, mkt cap around $300k!

[madeindet]

NEWS: KOAN Resonate Blends Exceeds $1 Million in Raised and Committed Funding for Growth Initiatives
February 18, 2020 07:04 AM Eastern Standard Time
CALABASAS, Calif.--(BUSINESS WIRE)--Resonate Blends, Inc. (OTCQB:KOAN), a cannabis-based holding company (“Resonate Blends” or “the Company”), announced today an update to shareholders on its funding initiatives, partnerships and development of the Koan product line from CEO and Chairman of Resonate Blends, Inc., Geoffrey Selzer.

Since taking operational control, we have raised or have committed in excess of $1,000,000 in fresh capital to support operations and to restructure and retire previous Textmunication debt
Tweet this
Dear Shareholders,

The management transition from Textmunication Holdings, Inc. (“Textmunication”) to Resonate Blends was complete as of January 20, 2020. It is our intention from here on to keep shareholders appraised of the Company’s progress across all fronts.

We started Resonate Blends with a simple mission --- to demystify cannabis. We developed the Resonate System to make Cannabis understandable, accessible and predictable to support the Wellness lifestyle. We empower people to live their best lives by developing proprietary and innovative branded products built on the science of plant medicine. We are passionate about raising the concept of the “experience targets” to a fine art.

The Company is working diligently to align the capital structure of the public company to the financial requirements of our operating entities. Our goal is to maximize the value of the company for its rightful owners, its shareholders. The previous management worked with a different financial structure and philosophy, and we have taken significant steps to rebuild the balance sheet around a model that supports long-term value. Since taking operational control, we have raised or have committed in excess of $1,000,000 in fresh capital to support operations and to restructure and retire previous Textmunication debt. Our focus is to eliminate any debt or financial instruments that could undermine the company’s share structure and operations.

As you know, we retired the Series D Convertible Preferred on December 11, 2019, and are committed to retiring a convertible note that was issued prior to our merger with Textmunication. We are finalizing definitive documents for a promissory note and continue to successfully raise money through our equity private placement memorandum (PPM). Our comprehensive funding approach provides us the flexibility and confidence needed to grow operations, incubate emerging cannabis/CBD companies and continue targeting new M&A into the holding company. We have made progress and are confident that over the next 30 to 45 days the capital structure will become even healthier and better aligned with the requirements of our strategic initiatives.

We continue to work closely with the Joiant team, our previously announced acquisition target, and will soon have new and exciting developments to report from Joiant. We will also provide an update on our product development, distribution plans and technical partnerships. Product development continues aggressively finalizing supply lines and finishing design, intellectual property protection and formulation on some very unique and compelling products. We are looking forward to sharing more information on that front very soon.

It is a very exciting time for us as we complete the transformation from Textmunication to Resonate Blends. Now that our financial goals are being achieved, we are pivoting our attention to the growth and development of the underlying operations. The Resonate team is experienced, engaged, and professional. Our financial, technical and product partners are also experienced, creative and are providing (and receiving) significant value . We are building a bright future for your company and are committed to clear and transparent communication as we support our business, financial partners, employees and shareholders.

We are very grateful for your continued support and you will be hearing from us again soon.

Geoffrey Selzer

CEO Resonate Blends Inc

About Resonate Blends, Inc. (OTCQB:KOAN)

[wolverine02]

INND News, https://ih.advfn.com/stock-market/USOTC/innerscope-hearing-techn-pk-INND/stock-news/81793803/innerscope-hearing-technologies-otc-innd-engages

[stock1ace1]

TRNX .265 Hod break coming again!!

[stock1ace1]

GFTX .0011 ~ Double bottom 122 mill o/s !

[resx18]

If you like ZERO DILUTION $ARTM is the play!

O/S 34,305,087 @ 03/12/20

Public Float
7,230,215
03/10/2020

https://www.otcmarkets.com/stock/ARTM/security

https://backend.otcmarkets.com/otcapi/company/financial-report/240013/content

[~ Blue ~]

BIOC skyrocketing HUGE RALLY

[High_Profits]

$PRED #RapidAntibodyTest #COVID19 [VIDEO]
Predictive Labs http://PredictiveLabs.com

Video Link
https://twitter.com/HighProfits_LLC/status/1243932940247203841

On the Front Lines of #COVID19 Assurance AB
#RapidTest #RapidTestKit #Saving Lives

[TheSerb]

$RXMD - HUGE FREAKING NEWS!!! PROFITS FINALLY!!! Progressive Care Reports Record $32M Revenues, 70% Jump in Gross Profits, Leadership in Contactless Prescription Delivery Accelerating Momentum
BY GlobeNewswire
— 7:00 AM ET 03/31/2020
MIAMI, FL, March 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Progressive Care Inc. ( RXMD
Loading...
Loading...
) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is very excited to announce the release of the Company’s audited Annual Report for 2019. The Company posted record-breaking data, which was defined by sequential quarterly improvement throughout the year in all major financial performance metrics, including EBITDA profitability in Q4 2019. In addition, the Company is pleased to report that this momentum has continued to define results so far in 2020, as the Company sees market share gains based on its established leadership position in-home delivery and disease prevention protocols which have become a critical competitive advantage due to concerns over the spread of Coronavirus Disease 2019 (“COVID-19”).

S. Parikh Mars, CEO of Progressive Care ( RXMD ), commented, “2019 was an extraordinary year for Progressive Care ( RXMD
Loading...
Loading...
). We confronted difficult challenges and put together the most impressive stretch of performance in our history in response. Each quarter – each month – was better than the last and now defines a fresh context for 2020.”

Key 2019 Annual Report Highlights

Consolidated monthly gross sales across all locations for 2019 totaled $32.6 million, representing year-over-year growth of 58% compared to the twelve months ended 12/31/2018,
Total Gross Profit across all locations for 2019 totaled $7.97 million, representing year-over-year growth of 70% compared to the twelve months ended 12/31/2018,
EBITDA for Q4 2019 turned positive, at $300,904,
2019 was characterized by four consecutive quarters of declining overall net losses.
Management believes that Progressive Care ( RXMD
Loading...
Loading...
) is now leveraging a strong competitive advantage in its core pharmacy segment due to the COVID-19 crisis. The prescription drug prescriber community has quantifiable financial incentives driven and defined by the risk of patient infection rates. This is even more acute in the geographic area defining the Company’s primary operational footprint (Florida), where demographic variables confer a greater risk in COVID-19 patient outcomes due to age-related factors.

Progressive Care ( RXMD
Loading...
Loading...
) was the first mover in the space in terms of home delivery and disease prevention and management. Competitors in the space are behind the curve. The Company believes risk-based financial incentives at the clinic and prescriber level are actively translating into market share growth that should show up in Q1 and Q2 2020 financial data.

Mars continued, “It is paramount that our shareholders know we are uniquely well-positioned to thrive in the current tragic COVID-19 environment. We have been doing home delivery for 13 years and used our expertise in infectious disease to become one of the first to implement contactless protocols for the safety of our patients and staff. Our competitors are trying to cobble something together on the fly. At our pharmacies, free same-day and next day delivery are standard, remote health monitoring is standard, adherence coaching is standard, safe delivery is standard. We lead the way in best practices as more and more pharmacies look to adopt some form of our model in the short run. This is our bread and butter, and we already see very clear evidence of market share gains based on liability consideration in the prescriber channel as a result.”

For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc. ( RXMD
Loading...
Loading...
)

[High_Profits]

$PRED ANTIBODY TESTS ARE JUST DAYS AWAY

https://www.zerohedge.com/health/papers-please-fauci-agrees-gates-covid-immunity-card-idea-has-merit












https://predictivelabs.com/

[winnotlose]

Clwd my friend. Virus gift of week

[TheSerb]

$RXMD - HUGE NEWS OUT! Progressive Care Doubles March Sales, Successfully Utilizing Its Market Leading Contactless RX Delivery Due to Covid-19 Pandemic
BY GlobeNewswire
— 7:00 AM ET 04/15/2020
MIAMI, FL, April 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for March 2020, which featured breakthrough growth in total sales and a new Company record in total number of prescriptions filled on sharp market share gains:

· Consolidated monthly gross sales across all locations totaled $3.6 million, representing year-over-year growth of 105% compared to March 2019,

· Prescriptions filled during the month came in at 47,467, representing year-over-year growth of 76% compared to March 2019,

· Prescriptions filled hit a new all-time monthly record for the Company in March,

· “Ready, Set, PrEP” Program for HIV prevention launched,

· Seeing continued growth in services targeting non-profit organizations,

· Will file with SEC for fully reporting status.

“Our market-leading contactless delivery experience has positioned Progressive Care ( RXMD
Loading...
Loading...
) to truly thrive in this uniquely challenging context, and that really showed through in March,” commented S. Parikh Mars, CEO of Progressive Care ( RXMD
Loading...
Loading...
). “Much of this growth is the result of patients and physicians choosing our pharmacies over grocery store and chain pharmacies to better protect themselves from exposure during this time. We have worked steadily to deliver prescriptions securely while adhering to contactless protocols during the pandemic.”

Management notes that March was a record-breaking month driven largely by heavy incentivization at the prescriber level to recommend pharmacy services that minimize the risk of patient infections. Progressive Care ( RXMD
Loading...
Loading...
) has earned a reputation in the physician community for safeguarding the health and wellbeing of patients.

The Company believes that this explosive wave of growth is best understood as a market share phenomenon, which is a dynamic that may continue to define results over the intermediate-term. The Company expects continued influxes of new patients over the next 30 days as patients are encouraged to stay at home. Furthermore, it does not expect added attrition of patients once the current crisis conditions wain as patients of the Company have high satisfaction rates.

“We have also launched our Ready, Set, PrEP Program for HIV prevention and we have worked steadily to add new relationships with not-for-profit clinics,” continued Mars. “We expect to have several of these clinics actively engaged with this service in Q3.”

For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc. ( RXMD
Loading...
Loading...
)

https://www.facebook.com/ProgressiveCareUS/

https://twitter.com/ProgressCareUS

PharmCo, LLC

https://www.facebook.com/pharmcorx/

https://twitter.com/PharmCoRx

Five Star RX

https://www.fivestarrx.com/

https://www.facebook.com/fivestarrx/

About Progressive Care Inc. ( RXMD
Loading...
Loading...
)

[High_Profits]

NEW $PRED FDA Registration Number ISSUED 04/20/2020

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?rid=248232



https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?rid=248232

[DikFritz]

Got KNOS today, how about ASKH tomorrow -:)

[stock1ace1]

Inpx $1.32 ~

[stock1ace1]

INPx $1.39s going fast

[stock1ace1]

SRTS $3 ***** BUYOUT ALL CASH rejected @4.00 a share !!

On May 26, 2020, Sensus Healthcare, Inc. (the “Company”) received an unsolicited offer to acquire all the outstanding shares of the Company at a price of $4.00 per share, in cash. Following consideration by and at the direction of its Board of Directors, the Company has rejected the offer.

[stock1ace1]

ESSCW .25 Get In Before Merger Or LOI takes place !!!

[Drugdoctor]

$PNTV.0042 just filed CHAPTER 11 BANKRUPTCY!! SCUMBAG-CEO-says-it-will-benefit-shareholders... SHEESH>>>

https://www.sec.gov/Archives/edgar/data/1037131/000149315220011567/ex99-1.htm

Players Network announced today via an 8K filing with SEC that has filed a petition for Chapter 11 reorganization



LAS VEGAS, NV (June 22nd, 2020) Players Network Inc. (PNTV.PK) announced today that it has filed for Chapter 11 reorganization.



This filing will provide the company the opportunity to reorganize its debt while also dealing with what it believes to be predatory lenders affecting the company’s stock. As disclosed in the filing, the company reserves its right to file adversary claims against these lenders.



A proposed debt restructuring plan was filed with the courts and the debt holders to which may result in a significant debt reduction paid over 5 years and simultaneously reduce and possibly eliminate the convertible overhang on the company’s stock. While nothing can be assured, the company is confident it will be able to arrive at a reasonable creditor settlement as soon as the company can get in front of the courts in about 60 days depending on scheduling.



This filing is the first step in a strategic plan to reorganize the company, develop stability, and bring value to its shareholders. Additional details regarding the company’s plan will be released shortly in line with the Chapter 11 guidelines.



Mark Bradley CEO of Players Network said, The debt combined with “The COVID 19 pandemic, which shuttered Las Vegas, essentially destroyed our sources of revenue and left the board with no option but to seek chapter 11 protection. I want to say for myself, the board, and our advisors that we are bullish about our reorganization plans and believe this filing is in the best interest of our shareholders. As we progress over the next weeks, these plans will be fully disclosed and outlined to our shareholders.”





https://www.sec.gov/Archives/edgar/data/1037131/000149315220011567/form8-k.htm

Item 1.03
Bankruptcy or Receivership.



Chapter 11 Filing



On June 17, 2020 (the “Petition Date”), the Company filed a voluntary petition commencing a case under chapter 11 of title 11 of the U.S. Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Nevada (the “Bankruptcy Court”). The Company’s chapter 11 case (the “Chapter 11 Case”) is being administered under the caption, In re: Players Network., Case No. 20-12890 - mkn. The Company will continue to operate its business as a “debtor-in-possession” under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Bankruptcy Court.



Item 2.04 Triggering Events that Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.


The commencement of the Chapter 11 Case described in Item 1.03 above may constitute an event of default that may accelerate the Company’s obligations under outstanding promissory notes in the aggregate approximate principal amount of up to $5,000,000 (collectively, the “notes and all debt combined”).



Any efforts to enforce the payment obligations under the Notes are automatically stayed as a result of the filing of the Chapter 11 Case, and the creditors’ rights of enforcement in respect of the Notes are subject to the applicable provisions of the Bankruptcy Code.



Item 7.01 Regulation FD Disclosure.


On June 19 , 2020, the Company issued a press release announcing the filing of the Chapter 11 Cases. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.



Cautionary Information Regarding Trading in the Company’s Securities



The Company cautions that trading in the Company’s securities during the pendency of the Chapter 11 Case is highly speculative and poses substantial risks. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery, if any, by the holders of the Company’s securities in the Chapter 11 Case.

[stock1ace1]

NOvn @.51 huge breakout !!!

[stock1ace1]

CHEK .55 **** About to go !!!

[trader_ron]

Easy 2x $HPMM 40M Low Float, CE being removed any day, in Revenue, #CBDedibles #Handsanitizer #Gummies https://hempnaturals.shop/

[stock1ace1]

CHEK .56 *** 50Ma break Huge Accumulation

[stock1ace1]

CYCC $4.67 ** Micro Float Running !

[stock1ace1]

CYCC $5.54 *** Short squeeze incoming !!

[stock1ace1]

AMRH 1.78 ** Pending Deal 3 mill o/s !! Micro floater gonna run hard


Pending Transaction With Jay Pharma Inc. ATLANTA , July 1, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced that the Company is continuing to work through the regulatory review process towards finalizing the proposed amalgamation transaction with Jay Pharma, Inc. ("Jay Pharma"),

[Drugdoctor]

$CMGO.0054 +23% - SEC reporting TOMORROW-NEW-TWEET-OUT>>>

$CMGO I have some very exciting news, we have just heard from the SEC and we are done with our review and as of end of day tomorrow we will be will be SEC reporting. It has been a long road back to here but we have made it!!!! Thanks for all the support and patience😃

— CMG Holdings Group Inc. (CMGO) (@CMGONews) July 6, 2020

[stock1ace1]

AMRH *2Mill Float + Pending Merger

$1.75


Pending Transaction With Jay Pharma Inc. ATLANTA , July 1, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced that the Company is continuing to work through the regulatory review process towards finalizing the proposed amalgamation transaction with Jay Pharma, Inc. ("Jay Pharma"),

[JusDePomme]

RSPI loooooooooooooooks ready bb

[Threeflight]

MITI Golden Cross taking place!

[stock1ace1]

Chek .57 Breaking out here big accumulation

[stock1ace1]

AIKI .97 Golden cross forming huge breakout

[JusDePomme]

VSYM $$$$$$breaking out chartz.....loooook extremely thin ask level 2

[stock1ace1]

IZEA $1.11 ~> buyers stepping up

[stock1ace1]

MYOS $1.29 *** Merger / 200 ma bounce !!

[resx18]

$NXGB NEWS DAVIE, Florida, July 15, 2020 /PRNewswire/ -- NxGen Brands Inc. (NXGB), announces the addition of a full product line of commercial, industrial, and residential cleaning supplies, disinfectants, and sanitizers.

NxGen Brands, Inc newly added line of products consist of proprietary and licensed formulations registered with the Environmental Protection Agency (EPA) and that follow Food and Drug Administration (FDA) guidelines in their composition and production for human interaction. These products have specific formulations designated for commercial, industrial, and residential markets. Some of the intended markets include bars, restaurants, schools, hotels, casinos, factories, various sectors of the travel industry, and the individual consumer given that NxGen Brands has developed the capability to provide options for purchase orders in a variety of sizes ranging from personal-use product quantity to 300 plus gallon totes.

Angel Burgos, CEO and President of NxGen Brands, commented, "We have been identifying diligently over the course of the past several months to offer the public a new addition to our already existing and popular product lines of CBD and CBG based goods. This new addition started out with our interest in high end topicals for pain management and condition treatment, which eventually lead to hand sanitizer, and ultimately brought us around full circle to put us where we need to be, and that is at the front line of our customers' needs. That is why we are now offering, what we anticipate being, a well-received and highly demanded line of health-focused products, which are all manufactured and processed in the USA. Currently we are setting up operations on global sales platforms such as Amazon and Shopify which gives our prod exposure to millions of potential customers with both commercial and private needs. We anticipate that both the marketplace and our shareholders will be thrilled with our innovations and new additions."

Products included in the commercial, industrial, and residential cleaning supplies, disinfectants, and sanitizers can be seen at our newly updated Corporate Website: www.nxgenbrands.com and for more information or to make bulk purchases, please contact by phone [phone] or email [e-mail].

[Lucky_Charm$]

*** TMXN *** Waking up here....

[stock1ace1]

MYOs $1.30 Merger news out

[stock1ace1]

TENX $1.07 golden cross breakout !

[resx18]

$NXGB Video is out!

[stock1ace1]

CHEK .63 *** Huge Breakout / accumulation

[stock1ace1]

ABiO $6.85 Breakout

[stock1ace1]

SENS .44 *** Breaking 50ma p/m

[stock1ace1]

SENS .46 Gapping & running

[JusDePomme]

VSYM huge huge breakout here July 30 meeting ICA

[stock1ace1]

SLBG .41 ~> There product big $$ maker !! ~~~> https://slingerbag.com/shop/

[reconranger]

How is this shit POS doing?-reconranger

[TheSerb]

$RXMD - DON'T MISS OUT!!! Progressive Care Reports June 2020 Performance Data: Preliminary Q2 Sales Up 33% to $9.32M
BY GlobeNewswire
— 7:00 AM ET 07/27/2020
Read Full Release

MIAMI, FL, July 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Progressive Care Inc. ( RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for June 2020, along with preliminary fiscal Q2 performance data, both of which demonstrate a continued robust trend of growth in sales, prescriptions, 340B income, and COVID- 19 testing service revenues.

Consolidated monthly gross sales across all locations during the month of June totaled $3.35 million, representing monthly sequential growth of 12% compared to May 2020
Consolidated preliminary sales for the three months ended June 30, 2020, totaled $9.32 million, representing quarterly year-over-year growth of 33.2%
Prescriptions filled during the month of June came in at 44,251, representing monthly sequential growth of 11% compared to May 2020
340B claim processing from FQHCs produced roughly $229K in net income, up over 80% on a monthly sequential basis
Expanded COVID-19 testing service to additional counties with strong demand, additional expansion underway
PharmcoRx locations performing COVID-19 tests:

“We had a tremendous quarter with another great month, and calendar Q3 is off to a busy start on all fronts, particularly as we continue to step to the frontline in COVID-19 testing services,” remarked S. Parikh Mars, CEO of Progressive Care ( RXMD
Loading...
Loading...
). “Preliminary numbers on Q2 look strong with growth on a consolidated y/y basis topping 33%. That is particularly gratifying given the extraordinary nature of the context that will forever define those three months. That said, for Floridians, the struggle is still very much ongoing, and we will continue to be there in the trenches with our valued patients, clients, customers, and provider partners.”

Management notes that the Company has been aggressively expanding its antibody testing operations. As noted in its release dated July 14, Progressive Care ( RXMD
Loading...
Loading...
) expanded its antibody testing regional footprint to include Palm Beach County. The Company plans to further expand this territory in the near future as well.

This service has been met with extremely strong demand at its Dade County location, depleting testing kit inventories through on-site administrations. In response to both this surge in demand and the expansion in regional coverage, the Company has implemented processes to ensure supply of antibody testing kits for sale and administration across all four counties.

“We have now established leadership in contactless delivery of pharmacy services and access to rapid results antibody testing in Dade, Broward, and Palm Beach counties,” added Mars. “We are grateful for the opportunity to extend the scope of that commitment wherever we can.”

For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc. ( RXMD
Loading...
Loading...
)
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/

Public Relations Contact:
Carlos Rangel
[e-mail]

[stock1ace1]

RHE $1.53 Golden cross 1.7mil o/s

[winnotlose]

Clwd today my friend

[stock1ace1]

HUSA $1.50 Going green bottoms in!

[CBDJunkie401]

SPRWF released a PR the other day that went totally unnoticed!

They are a very reputable marijuana and CBD company that does $50 M a year in revenues. They released a PR stating that they have reworked their REMAINING debt so that NO SHARES can be sold towards the payment of the debt under 28 cents per share.

The stock is at 16 cents a share. That means no dilution and it also means the company and debt holders are going to do all they can to get the stock back above that 28 cent share marker. It is a no brainer!

https://www.otcmarkets.com/stock/SPRWF/news/Supreme-Cannabis-Announces-Agreement-to-Partially-Convert-and-Amend-Debentures?id=269595

The total principal amount of convertible Debentures outstanding will be reduced from $100.0 million to $36.5 million and the maturity date will be extended from October 19, 2021 to September 1, 2025 unless repurchased, redeemed or converted prior to maturity. The remaining Debentures will accrete at a rate of 11.06% per annum, compounding on a semi-annual basis commencing on September 1, 2020, and ending on September 1, 2023. The accreted portion of the principal is payable in cash but does not bear cash interest and is not convertible into the Company's common shares. The accreted portion of the principal will be evidenced by a separate series of debentures, which will not be listed on the Toronto Stock Exchange.

The conversion price of the remaining convertible Debentures outstanding will be reduced from $2.45 per share to $0.285 per share and annual interest payments will be reduced to $2.9 million from $6.0 million. The Company will have the right to force the conversion of the remaining principal amount of the convertible Debentures outstanding at the Conversion Price on not less than 30 days' notice if the daily volume weighted average trading price of the Company's common shares is greater than $0.45 for any 10 consecutive trading days. The principal amount of the remaining Debentures will amortize at 1.0% per month over the 24 months prior to maturity.

[CBDJunkie401]

SPRWF released a PR the other day that went totally unnoticed!

They are a very reputable marijuana and CBD company that does $50 M a year in revenues. They released a PR stating that they have reworked their REMAINING debt so that NO SHARES can be sold towards the payment of the debt under 28 cents per share.

The stock is at 16 cents a share. That means no dilution and it also means the company and debt holders are going to do all they can to get the stock back above that 28 cent share marker. It is a no brainer!

https://www.otcmarkets.com/stock/SPRWF/news/Supreme-Cannabis-Announces-Agreement-to-Partially-Convert-and-Amend-Debentures?id=269595

The total principal amount of convertible Debentures outstanding will be reduced from $100.0 million to $36.5 million and the maturity date will be extended from October 19, 2021 to September 1, 2025 unless repurchased, redeemed or converted prior to maturity. The remaining Debentures will accrete at a rate of 11.06% per annum, compounding on a semi-annual basis commencing on September 1, 2020, and ending on September 1, 2023. The accreted portion of the principal is payable in cash but does not bear cash interest and is not convertible into the Company's common shares. The accreted portion of the principal will be evidenced by a separate series of debentures, which will not be listed on the Toronto Stock Exchange.

The conversion price of the remaining convertible Debentures outstanding will be reduced from $2.45 per share to $0.285 per share and annual interest payments will be reduced to $2.9 million from $6.0 million. The Company will have the right to force the conversion of the remaining principal amount of the convertible Debentures outstanding at the Conversion Price on not less than 30 days' notice if the daily volume weighted average trading price of the Company's common shares is greater than $0.45 for any 10 consecutive trading days. The principal amount of the remaining Debentures will amortize at 1.0% per month over the 24 months prior to maturity.

[stock1ace1]

OTLK $1.33 *** Phase 3 Data Any day now !

[stock1ace1]

NOVN .65 ***

[Threeflight]

CTYX the news is very very imminent. Going to be amazing.

RXMD too.

Look at the charts. :)

[stock1ace1]

Abus $3.80 Breakout this came out


Moderna says uncertain about coronavirus vaccine patent exclusivity REUTERS 10:39 AM ET 8/11/2020 Symbol Last Price Change MRNA 70.335up -1.675 (-2.33%) ABUS 3.4838down -0.1762 (-4.81%) QUOTES AS OF 11:46:42 AM ET 08/11/2020 Aug 11 (Reuters) - Moderna Inc(MRNA) said there was a possibility it was not the first company to make breakthroughs claimed in its patent applications, including those for its experimental coronavirus vaccine, according to a recent regulatory filing. The statement by the U.S. drug developer was made in a quarterly filing on Aug. 6 under mandatory disclosures of risks to its business. Moderna's (MRNA) prior quarterly filings with U.S. regulators did not have the disclosure. "For this and other reasons, we may be unable to secure desired patent rights, thereby losing exclusivity," the company said. (https://bit.ly/2PISREC) The company has received funding from the U.S. government to develop its coronavirus vaccine, and in July lost a bid to invalidate a U.S. patent owned by Arbutus Biopharma Corp(ABUS) that poses a potential obstacle to Moderna's(MRNA) efforts to develop next-generation vaccines. "We cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent protection of such inventions, including mRNA-1273," the company said. (Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

[resx18]

$SBEV 10-Q out 1500% rev increase over last year

https://www.otcmarkets.com/filing/html?id=14332776&guid=pL_6UHypnghQbth

[stock1ace1]

FLUx $5.35 New Ev play !!

[stock1ace1]

POAI 1.18$ contract w/ big pharm ~> Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is excited to announce that its Soluble Biotech division, a provider of soluble and stable formulations for proteins, just received its first substantial contract from a major pharmaceutical company since being acquired by Predictive Oncology in May 2020. The project involves protein expression followed by solubility studies, areas of significant expertise within Soluble Biotech.
“Our first contract is a major milestone and validates our recent move into a new, larger facility”, says Dr. Larry DeLucas, former NASA astronaut and founder of Soluble Biotech. “We quadrupled our laboratory and office space, some of which will eventually include a GMP facility. Additionally, we acquired state-of-the-art equipment to support our fermentation, therapeutic protein formulation development and protein stability studies. With our first contract on the books, and expanded capacity, the future is bright. We are currently negotiating several additional contracts with biotechnology and pharmaceutical companies.”

[resx18]

$SBEV announces today additional Walmart locations throughout the U.S. for its SALT Naturally flavored Tequila with 100% Agave.

https://www.otcmarkets.com/stock/SBEV/news/story?e&id=1674837

[stock1ace1]

CMGO .0065 Golden Cross Insiders buying!!

[resx18]

$SBEV NEWS Fort Lauderdale, Florida–(Newsfile Corp. – August 24, 2020) – Splash Beverage Group, Inc. (OTC PINK: SBEV) (https://www.SplashBeverageGroup.com) (“the Company”), a holding company of leading portfolio of beverage brands, announces today that Major Brands, a leading Missouri distributor of premium spirits, wine, beer and non-alcoholic beverages, and the largest distributor that remains Missouri-owned and operated, will be distributing the Company’s SALT Naturally Flavored Tequila with 100% Agave throughout the state of Missouri within its base of 9000 retail customers statewide including Walmart Spirits locations. https://traderalert.club/sbev-leading-missouri-beverage-distributor-with-over-9000-r/

[stock1ace1]

Idex $1.24 Breaking out !

[stock1ace1]

Creg $2.50 ** 36$ Book value way undervalued !!

2 Mill o/s $62.7 Mill in cash per last Q